These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9557692)

  • 21. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma.
    Hu LF; Zabarovsky ER; Chen F; Cao SL; Ernberg I; Klein G; Winberg G
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2399-409. PubMed ID: 1681026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
    Eliopoulos AG; Young LS
    Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Functional analysis of Epstein-Barr virus latent membrane proteins (LMP1) in patients with limphoproliferative disorders].
    Smirnova KV; Diduk SV; Gurtsevich VÉ
    Biomed Khim; 2011; 57(1):114-26. PubMed ID: 21516783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of wild type and deleted latent membrane protein 1 (LMP1) of Epstein-Barr virus in clinical biopsy material.
    Nicholls J; Hahn P; Kremmer E; Fröhlich T; Arnold GJ; Sham J; Kwong D; Grässer FA
    J Virol Methods; 2004 Mar; 116(1):79-88. PubMed ID: 14715310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1.
    Franken M; Devergne O; Rosenzweig M; Annis B; Kieff E; Wang F
    J Virol; 1996 Nov; 70(11):7819-26. PubMed ID: 8892903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1.
    Nguyen-Van D; Ernberg I; Phan-Thi Phi P; Tran-Thi C; Hu L
    Virus Genes; 2008 Oct; 37(2):273-81. PubMed ID: 18663567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos.
    Vaysberg M; Hatton O; Lambert SL; Snow AL; Wong B; Krams SM; Martinez OM
    J Biol Chem; 2008 Dec; 283(52):36573-85. PubMed ID: 18986987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense to Epstein Barr Virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBV-transformed B lymphocytes.
    Masciarelli S; Mattioli B; Galletti R; Samoggia P; Chichiarelli S; Mearini G; Mattia E
    Oncogene; 2002 Jun; 21(26):4166-70. PubMed ID: 12037673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
    Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
    Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells.
    Pai S; O'Sullivan BJ; Cooper L; Thomas R; Khanna R
    J Virol; 2002 Feb; 76(4):1914-21. PubMed ID: 11799186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.
    Miller WE; Mosialos G; Kieff E; Raab-Traub N
    J Virol; 1997 Jan; 71(1):586-94. PubMed ID: 8985387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway.
    Vockerodt M; Haier B; Buttgereit P; Tesch H; Kube D
    Virology; 2001 Feb; 280(2):183-98. PubMed ID: 11162833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
    Sjöblom A; Nerstedt A; Jansson A; Rymo L
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
    Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF
    Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [LMP1 gene variants of Epstein-Barr virus in patients with some lymphoproliferative malignancies].
    Gurtsevich VE; Goncharova EV; Shcherbak LN; Kovrigina AM; Falaleeva NA; Iakovleva LS; Stepina VN; Popova AA; Sterlikova AA; Osmanov EA; Pavlish OA
    Vopr Virusol; 2006; 51(2):35-9. PubMed ID: 16756177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway.
    Dudziak D; Kieser A; Dirmeier U; Nimmerjahn F; Berchtold S; Steinkasserer A; Marschall G; Hammerschmidt W; Laux G; Bornkamm GW
    J Virol; 2003 Aug; 77(15):8290-8. PubMed ID: 12857898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LMP1 strain variants: biological and molecular properties.
    Mainou BA; Raab-Traub N
    J Virol; 2006 Jul; 80(13):6458-68. PubMed ID: 16775333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
    Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ancient variants of the Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4): hypotheses and facts.].
    Smirnova KV; Senyuta NB; Lubenskaya AK; Dushenkina TE; Gurtsevich VE
    Vopr Virusol; 2020; 65(2):77-86. PubMed ID: 32515563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.